Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb;108(2):326-332.
doi: 10.1002/jbm.b.34391. Epub 2019 Apr 23.

Polyglycolic Acid-Collagen Tube Combined With Collagen-Binding Basic Fibroblast Growth Factor Accelerates Gait Recovery in a Rat Sciatic Nerve Critical-Size Defect Model

Affiliations

Polyglycolic Acid-Collagen Tube Combined With Collagen-Binding Basic Fibroblast Growth Factor Accelerates Gait Recovery in a Rat Sciatic Nerve Critical-Size Defect Model

Hisako Fujimaki et al. J Biomed Mater Res B Appl Biomater. .

Abstract

Several nerve conduits have been investigated for their potential as alternative sources of autografts for bridging neural gaps. However, autologous nerve transplants remain the most effective for nerve repair. We examined clinically approved nerve conduits containing collagen and polyglycolic acid (PGA-c) combined with collagen-binding basic fibroblast growth factor (bFGF) containing a polycystic kidney disease (PKD) domain and collagen binding domain (CBD) (bFGF-PKD-CBD) in a rat 15-mm sciatic nerve critical-size defect model. The treatment groups were: PGA-c immersed in phosphate-buffered saline (PBS) (PGA-c/PBS group), bFGF (PGA-c/bFGF group), or bFGF-PKD-CBD (PGA-c/bFGF-PKD-CBD group), and no treatment (Defect group). Gait and histological analyses were performed. Four weeks after treatment, the recovery rate of the paw print area was significantly greater in the PGA-c/bFGFPKD-CBD group than the PGA-c/PBS and PGA-c/bFGF groups. Mean intensity of paw prints was significantly greater in the PGA-c/bFGF-PKD-CBD group than the PGA-c/PBS and Defect groups. Swing time was significantly greater in the PGA-c/PBS, PGA-c/bFGF, and PGA-c/bFGF-PKD-CBD groups than the Defect group. At 8 weeks, all three parameters were significantly greater in the PGA-c/PBS, PGA-c/bFGF, and PGA-c/bFGF-PKD-CBD groups than the Defect group. Regenerated myelinated fibers were observed in 7/8 (87.5%) rats in the PGA-c/bFGF-PKD-CBD group after 8 weeks, and in 1/8 (12.5%) and 3/8 (37.5%) rats in the PGA-c/PBS and PGA-c/bFGF groups, respectively. PGA-c/bFGF-PKD-CBD composites may be promising biomaterials for promoting functional recovery of long-distance peripheral nerve defects in clinical practice.

Keywords: basic fibroblast growth factor (bFGF); collagen-binding domain; peripheral nerve regeneration; polyglycolic acid-collagen tube.

Similar articles

See all similar articles

References

REFERENCES

    1. Andrades JA, Santamaria JA, Wu LT, Hall FL, Nimni ME, Becerra J. Production of a recombinant human basic fibroblast growth factor with a collagen binding domain. Protoplasma 2001;218:95-103.
    1. Arslantunali D, Dursun T, Yucel D, Hasirci N, Hasirci V. Peripheral nerve conduits: Technology update. Medical Devices (Auckland, N.Z.) 2014;7:405-424.
    1. Clavijo-Alvarez JA, Nguyen VT, Santiago LY, Doctor JS, Lee WP, Marra KG. Comparison of biodegradable conduits within aged rat sciatic nerve defects. Plastic and Reconstructive Surgery 2007;119:1839-1851.
    1. Cui Y, Lu C, Meng D, Xiao Z, Hou X, Ding W, Kou D, Yao Y, Chen B, Zhang Z, Li J, Pan J, Dai J. Collagen scaffolds modified with CNTF and bFGF promote facial nerve regeneration in minipigs. Biomaterials 2014;35:7819-7827.
    1. Fan J, Zhang H, He J, Xiao Z, Chen B, Xiaodan J, Dai J, Xu R. Neural regrowth induced by PLGA nerve conduits and neurotrophin-3 in rats with complete spinal cord transection. Journal of Biomedical Materials Research. Part B, Applied Biomaterials 2011;97:271-277.

LinkOut - more resources

Feedback